Contractor
BIOCRYST PHARMACEUTICALS INC
DURHAM, NC
- UEI
- MGXADJ6SCLJ5
- Parent UEI
- MGXADJ6SCLJ5
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$14,088,8391
Awards
6
Agencies served
2
Active from May 5, 2021 to Oct 1, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79721D0166 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | May 5, 2021 | — |
| 36E79726A0015 BPA FOR ORLADEYO AND RAPIVAB | Department of Veterans Affairs | — | Jun 2, 2026 | — |
| 36C24926F0152 EMERGENCY ORLADEYO | Department of Veterans Affairs | NC | May 21, 2026 | $30,293 |
| 36C26026F0294 ORLADEYO 150MG CAP | Department of Veterans Affairs | MO | May 19, 2026 | $151,465 |
| 36C26025F0296 BULK ORDER ORLADEYO FOR VETERAN CARE. | Department of Veterans Affairs | MO | Mar 31, 2026 | $29,408 |
| 75A50324F80012 EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI MODIFICATION TO ADJUST END DATE DUE TO OPTIONS NOT EXERCISED. | Department of Health and Human Services | NC | Mar 27, 2026 | $13,877,674 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MGXADJ6SCLJ5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.